As for the E484K mutation, characteristic of the SA and BR P.1 variant RBDs, it was reported to be “associated with escape from neutralizing antibodies”, which adversely affects the efficacy of spike protein-dependent COVID-19 vaccines [26]. Here, CHMP5 is linked to COVID-19.